&nbsp;

Votre opinion est importante Nous sommes a lécoute_Francais.pdf

Jun 2019

Document

VotreOpinionEstImportanteNousSommesAlécouteFrancais.pdf

Jun 2019

Regimen

GEMC

Cancer Type:

Hematologic,

Lymphoma - T-cell,

Rare Diseases

Intent: Palliative

Drugs Used:

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2019

Blog post

Guidelines ensure consistent high-quality care across the province

Dr. Leta Forbes, Medical OncologistProvincial Head, Systemic Treatment ProgramOntario Health (Cancer Care Ontario) Reactions to the injection of...

Sep 2019

Guidelines and Advice

Vaping products including e-cigarettes

Status: Current
ID: N/A
Version: 2

Jan 2023

Regimen

VENE+OBIN

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - in Combination with Venetoclax for Previously Untreated Chronic Lymphocytic Leukemia

Exceptional Access Program

venetoclax - in Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Drugs Used:

oBINutuzumab,

venetoclax

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2023

Regimen

GDP+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2020

Statistical Reports

Glossary

Document

GEMCNPAC(W).pdf

May 2020

Document

GEMCNPAC(W)-FR.pdf

Jun 2020

Regimen

GEMOD

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Adjuvant, Curative, Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2020

Regimen

GEMOX

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative, Curative, Adjuvant

Drugs Used:

gemcitabine,

oxaliplatin

... Show more tags